Canada
# |
Name |
Goodwill |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 60.24 M
|
Dec. 31, 2023 | USD 4.02 | 0.45% |
|
Canada |
|
2 |
USD 47.81 M
|
Dec. 31, 2023 | USD 3.17 | -1.86% |
|
Canada |
|
3 |
USD 15.71 M
|
Dec. 31, 2023 | USD 9.31 | -2.03% |
|
Canada |
|
4 |
USD 12.02 M
|
Dec. 31, 2023 | USD 14.60 | -0.95% |
|
Canada |
|
5 |
USD 10.28 M
|
March 31, 2024 | USD 2.13 | -19.44% |
|
Canada |
|
6 |
USD 0.00
|
Dec. 31, 2023 | USD 2.91 | -1.79% |
|
Canada |
|
7 |
USD 0.00
|
Aug. 31, 2024 | USD 1.89 | 1.61% |
|
Canada |
|
8 |
USD 0.00
|
Sept. 30, 2023 | USD 1.91 | 1.06% |
|
Canada |
|
9 |
USD 0.00
|
Dec. 31, 2023 | USD 6.18 | -0.57% |
|
Canada |
|
10 |
USD 0.00
|
Dec. 31, 2023 | USD 1.22 | 2.52% |
|
Canada |
|
11 |
USD 0.00
|
Nov. 30, 2023 | USD 1.71 | 12.04% |
|
Canada |
|
12 |
USD 0.00
|
Dec. 31, 2023 | USD 39.98 | -1.21% |
|
Canada |
|
13 |
USD 0.00
|
Dec. 31, 2023 | USD 0.95 | 7.20% |
|
Canada |
|
14 |
USD 0.00
|
Dec. 31, 2023 | USD 7.95 | -0.62% |
|
Canada |
|
15 |
USD 0.00
|
June 30, 2024 | USD 3.13 | -0.64% |
|
Canada |
The Clinical Trials company in Canada with the highest Goodwill is Knight Therapeutics Inc. (Toronto Stock Exchange: GUD.TO) at USD 60.24 M.
The Clinical Trials company in Canada with the lowest Goodwill is InMed Pharmaceuticals Inc. (NasdaqCM: INM) at USD 0.00.
The top 10 Clinical Trials companies in Canada by Goodwill are Knight Therapeutics Inc., AbCellera Biologics Inc., Cipher Pharmaceuticals Inc., Zymeworks Inc., Medexus Pharmaceuticals Inc., HLS Therapeutics Inc., Lexaria Bioscience Corp., Edesa Biotech, Inc., Profound Medical Corp. and Repare Therapeutics Inc..
The bottom 10 Clinical Trials companies in Canada by Goodwill are InMed Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., XORTX Therapeutics Inc., Xenon Pharmaceuticals Inc., Theratechnologies Inc., Repare Therapeutics Inc., Profound Medical Corp., Edesa Biotech, Inc., Lexaria Bioscience Corp. and HLS Therapeutics Inc..